Eli Lilly gets USFDA okay for updated Kisunla label with new dosing in early symptomatic Alzheimer's disease Ruchika Sharma10 July 2025 12:58 PM ISTIndianapolis: Eli Lilly and Company has received approval from the U.S. Food and Drug Administration (FDA) for a label update with a...
Medical Bulletin 03/Jul/2025 Dr. Bhumika Maikhuri3 July 2025 3:00 PM ISTHere are the top medical news for the day:Loneliness Affects 1 in 6 Globally, WHO Warns of Rising Health and Social CrisisThe World Health...
USFDA greenlights label update for Eli Lilly Amyvid to support Alzheimer's disease diagnosis in patients Ruchika Sharma26 Jun 2025 2:15 PM ISTIndianapolis: Eli Lilly and Company has recieved approval from the U.S. Food and Drug Administration (U.S. FDA) for a label update for Amyvid...
Eli Lilly Kisunla secures Australian nod for early symptomatic Alzheimer's disease Ruchika Sharma22 May 2025 2:29 PM ISTIndianapolis: Eli Lilly and Company has received marketing authorization from the Australian Therapeutic Goods Administration (TGA) for...
USFDA clears first blood test used in diagnosing Alzheimer's Disease Ruchika Sharma19 May 2025 5:03 PM ISTThe U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing...
USFDA nod to Leqembi IV maintenance dosing for treatment of early Alzheimer's Disease: Eisai, Biogen Ruchika Sharma27 Jan 2025 12:22 PM ISTTokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental...
JnJ Posdinemab gets USFDA Fast Track Designation for treatment of Alzheimer's disease Ruchika Sharma9 Jan 2025 1:30 PM ISTPosdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific phosphorylated tau.
AbbVie concludes acquisition of Aliada Therapeutics Ruchika Sharma15 Dec 2024 10:00 AM ISTNorth Chicago, Ill: AbbVie has announced that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada...
AbbVie to acquire Aliada Therapeutics for USD 1.4 billion in cash Ruchika Sharma2 Nov 2024 1:00 PM ISTNorth Chicago: AbbVie and Aliada Therapeutics have announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology...
Eli Lilly Kisunla bags marketing authorization in Great Britain to treat mild cognitive impairment, mild dementia due to Alzheimer's Disease Ruchika Sharma30 Oct 2024 10:00 AM ISTIndianapolis: Eli Lilly and Company has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing...
Medical Bulletin 15/ October/ 2024 Dr. Bhumika Maikhuri15 Oct 2024 3:00 PM ISTHere are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 American adults commissioned...
First sign of Alzheimer's linked to Quality of HDL in Women: Study Dr. Bhumika Maikhuri15 Oct 2024 8:45 AM ISTHigher levels of HDL-C-known as the "good cholesterol"-have been shown to correlate with heightened risk for Alzheimer's disease. A new study...
